OSTX · OS Therapies Inc
AI read · Bad for OSTX
The AI's read
OS Therapies filed a prospectus supplement that permits selling stockholders to resell up to 5,874,094 shares of common stock. That step increases the number of shares those holders may put into the market and therefore raises potential selling pressure. There is no new financing or partnership in the filing; the only affirmative company step was supplying a legal opinion for the resale registration.